Document Detail


Diagnosis and management of anaemia and iron deficiency in patients with haematological malignancies or solid tumours in France in 2009-2010: The AnemOnHe study.
MedLine Citation:
PMID:  22044579     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
OBJECTIVE: To describe the management of anaemia in 2009-2010 in France in patients with haematological malignancies (HM) or solid tumours (ST). METHODS: Retrospective observational study in 57 centres, enrolling adult patients with HM or ST treated for an episode of anaemia (duration of the episode ⩾3months occurring in the last 12months). RESULTS: 220 patients with ST (breast, 18%; lung, 18%) and 56 with HM (lymphoma, 60%) were included (median age, 68years; female, 53%). Mean haemoglobin level at anaemia diagnosis was 9.3±1.4g/dL (<8g/dL for 16%) and 9.8±1.1g/dL (<8g/dL for 6%) in HM and ST patients, respectively. At least one parameter of iron deficiency (ferritin, transferrin saturation) was assessed in 26% of HM and 19% of ST patients. Treatment of anaemia included erythropoiesis-stimulating agents (ESA) for 98% of HM and 89% of ST patients. Iron was prescribed to 14% (oral, 12%; intravenous, 2%) of HM patients and to 42% (oral, 17%; intravenous, 25%) of ST patients. The rates of blood transfusions were high: 70% in HM and 46% in ST patients; transfusions alone or administrated with ESA were more frequent in patients with Hb <8g/dL. CONCLUSION: Although recent guidelines recommend evaluating iron deficiency and correcting anaemia by using intravenous iron, our study in cancer patients evidenced that ESA and blood transfusions are still frequently used as the treatment of anaemia in cancer patients. Iron deficiency is insufficiently assessed (only one patient among five) and as a consequence iron deficiency is most likely insufficiently treated.
Authors:
Marc Spielmann; Elisabeth Luporsi; Isabelle Ray-Coquard; Stéphane de Botton; David Azria; Sigismond Lasocki; Antoine Lafuma; Lamine Mahi; Gilbert Deray; Roland Bugat
Related Documents :
9374139 - Local injection into mimetic muscles of botulinum toxin a for the treatment of facial l...
14724819 - Screening for barrett's esophagus in colonoscopy patients with and without heartburn.
10770369 - Esophageal lichen planus: the mayo clinic experience.
3786789 - Barrett esophagus: decreased esophageal clearance shown by radionuclide esophageal scin...
11115439 - Effects of esophageal acid perfusion on airway hyperresponsiveness in patients with bro...
3497189 - Esophageal perforation after fiberoptic variceal sclerotherapy.
8424359 - Parietal lobe abnormalities detected with mr in patients with infantile autism.
17593669 - Changing chronobiology of cardiovascular outcome following prophylaxis.
8550259 - Instrumented analysis of the pivot shift phenomenon after reconstruction of the anterio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-31
Journal Detail:
Title:  European journal of cancer (Oxford, England : 1990)     Volume:  -     ISSN:  1879-0852     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-11-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9005373     Medline TA:  Eur J Cancer     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Affiliation:
Medical Oncology Department, Institut Gustave Roussy, Villejuif, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immunomodulatory properties of Xylaria nigripes in peritoneal macrophage cells of Balb/c mice.
Next Document:  A giant plexiform schwannoma of the brachial plexus: case report.